Cargando…

Contribution of the L-Type Amino Acid Transporter Family in the Diagnosis and Treatment of Prostate Cancer

The L-type amino acid transporter (LAT) family contains four members, LAT1~4, which are important amino acid transporters. They mainly transport specific amino acids through cell membranes, provide nutrients to cells, and are involved in a variety of metabolic pathways. They regulate the mTOR signal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xue, Sakamoto, Shinichi, Wei, Jiaxing, Pae, Sangjon, Saito, Shinpei, Sazuka, Tomokazu, Imamura, Yusuke, Anzai, Naohiko, Ichikawa, Tomohiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094571/ https://www.ncbi.nlm.nih.gov/pubmed/37047148 http://dx.doi.org/10.3390/ijms24076178

Ejemplares similares

Prognostic Value of High-Sensitivity Modified Glasgow Prognostic Score in Castration-Resistant Prostate Cancer Patients Who Received Docetaxel
por: Ando, Keisuke, et al.
Publicado: (2021)

Machine-learning predicts time-series prognosis factors in metastatic prostate cancer patients treated with androgen deprivation therapy
por: Saito, Shinpei, et al.
Publicado: (2023)

Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma
por: Maimaiti, Maihulan, et al.
Publicado: (2020)

Left ileal conduit: A case report
por: Nakamura, Kazuyoshi, et al.
Publicado: (2019)

Successful treatment of metastatic bladder cancer by gemcitabine‐cisplatin re‐challenge after pembrolizumab
por: Arai, Takayuki, et al.
Publicado: (2021)

Relationship between Preoperative Pyuria and Bacille Calmette-Guerin Treatment in Intravesical Recurrence after Transurethral Resection of High-Risk, Non-Muscle Invasive, Bladder Carcinoma: A Retrospective Study of Human Data
por: Tsukamoto, Ryo, et al.
Publicado: (2023)

Expression of tertiary lymphoid structure in deferred cytoreductive nephrectomy of metastatic renal cell carcinoma treated with nivolumab plus ipilimumab
por: Sazuka, Tomokazu, et al.
Publicado: (2021)

Characterization of the expression of LAT1 as a prognostic indicator and a therapeutic target in renal cell carcinoma
por: Higuchi, Kosuke, et al.
Publicado: (2019)

Tumor localization by Prostate Imaging and Reporting and Data System (PI-RADS) version 2.1 predicts prognosis of prostate cancer after radical prostatectomy
por: Fujimoto, Ayumi, et al.
Publicado: (2023)

Revision of CHAARTED and LATITUDE criteria among Japanese de novo metastatic prostate cancer patients
por: Kanesaka, Manato, et al.
Publicado: (2021)

Contribution of LAT1-4F2hc in Urological Cancers via Toll-like Receptor and Other Vital Pathways
por: Zhao, Xue, et al.
Publicado: (2022)

Tumor Location and a Tumor Volume over 2.8 cc Predict the Prognosis for Japanese Localized Prostate Cancer
por: Baba, Haruki, et al.
Publicado: (2022)

Cushing's syndrome in pregnancy in which laparoscopic adrenalectomy was safely performed by a retroperitoneal approach
por: Takeuchi, Nobuyoshi, et al.
Publicado: (2023)

A case of metastatic renal cell carcinoma successfully treated with deferred cytoreductive nephrectomy following lenvatinib plus pembrolizumab combination therapy
por: Sato, Hiroaki, et al.
Publicado: (2023)

A case of ipsilateral three simultaneous renal cell carcinomas with different histologic types
por: Tanaka, Satoki, et al.
Publicado: (2023)

A case of bladder cancer after bilateral lung transplantation following bone marrow transplantation
por: Arai, Yutaro, et al.
Publicado: (2023)

The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2
por: Maimaiti, Maihulan, et al.
Publicado: (2021)

Interferon treatment for Japanese patients with favorable-risk metastatic renal cell carcinoma in the era of targeted therapy
por: Sazuka, Tomokazu, et al.
Publicado: (2015)

Functional analysis of LAT3 in prostate cancer: Its downstream target and relationship with androgen receptor
por: Rii, Junryo, et al.
Publicado: (2021)

Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment
por: Hayashi, Keitaro, et al.
Publicado: (2017)

Usefulness of Renal Autotransplantation for Radiotherapy-induced Renovascular Hypertension
por: Wakabayashi, Shinichi, et al.
Publicado: (2019)

Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer
por: Sugiura, Masahiro, et al.
Publicado: (2020)

Analysis of Preoperative Detection for Apex Prostate Cancer by Transrectal Biopsy
por: Sazuka, Tomokazu, et al.
Publicado: (2013)

Tumor‐suppressive microRNA‐223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer
por: Kurozumi, Akira, et al.
Publicado: (2015)

Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer
por: Nishikawa, Rika, et al.
Publicado: (2014)

FOXA1 Promotes Tumor Progression in Prostate Cancer via the Insulin-Like Growth Factor Binding Protein 3 Pathway
por: Imamura, Yusuke, et al.
Publicado: (2012)

Extracellular Vesicles in Bone Metastasis: Key Players in the Tumor Microenvironment and Promising Therapeutic Targets
por: Tamura, Takaaki, et al.
Publicado: (2020)

Molecular Mechanism of Ochratoxin A Transport in the Kidney
por: Anzai, Naohiko, et al.
Publicado: (2010)

Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer
por: Goto, Yusuke, et al.
Publicado: (2016)

L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism
por: Sato, Miku, et al.
Publicado: (2021)

Hypouricemia and Urate Transporters
por: Otani, Naoyuki, et al.
Publicado: (2022)

Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer
por: OKATO, ATSUSHI, et al.
Publicado: (2016)

The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer
por: Goto, Yusuke, et al.
Publicado: (2014)

Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target
por: Yamada, Yasutaka, et al.
Publicado: (2019)

Denosumab-related osteonecrosis of the jaw in a patient with bone metastases of prostate cancer: A case report and literature review
por: Yoshimura, Hitoshi, et al.
Publicado: (2017)

Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer
por: Goto, Yusuke, et al.
Publicado: (2017)

Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy
por: Yamada, Yasutaka, et al.
Publicado: (2018)

Enhanced production of γ-amino acid 3-amino-4-hydroxybenzoic acid by recombinant Corynebacterium glutamicum under oxygen limitation
por: Kawaguchi, Hideo, et al.
Publicado: (2021)

Pirin: a potential novel therapeutic target for castration‐resistant prostate cancer regulated by miR‐455‐5p
por: Arai, Takayuki, et al.
Publicado: (2018)

Structural basis for amino acid transport by the CAT family of SLC7 transporters
por: Jungnickel, Katharina E. J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p308ck366guiue8bjstd3etpla